| Old Articles: <Older 7161-7170 Newer> |
|---|
 |
The Motley Fool
February 11, 2011
Brian Orelli |
Biotech Optimists Throw In the Towel As the chance of survival improves, the stock falls. Wait, what?   |
The Motley Fool
February 11, 2011
Rex Moore |
Highest-Yielding Health Care Stocks (You Might Actually Want to Buy) How to combine high yield with low risk. |
BusinessWeek
February 10, 2011
Rob Waters |
Sangamo's Bet Against AIDS: Gene Therapy Sangamo's stock has more than doubled since July 6, when the company, with no products on the market, reported success of its gene therapy approach in mice in the journal Nature Biotechnology. |
The Motley Fool
February 10, 2011
Brian Orelli |
Breathe Easier, Join the Competition Novartis' strategy is a good one. |
The Motley Fool
February 9, 2011
Rich Smith |
What's Behind the Run-Up at Curis? One word: earnings. |
The Motley Fool
February 9, 2011
Brian Orelli |
Once a Decade Isn't Enough, Elan Elan posts its first operating profit in 10 years. |
The Motley Fool
February 9, 2011
Luke Timmerman |
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones Is there more to Amgen than "Dmab"? |
The Motley Fool
February 8, 2011
Brian Orelli |
A Few Extra Years of Sales? Yes, Please! An EU-Canadian proposal could help drugmakers. |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Finding a Cure for Cancer: The Option Market's Favorite Ideas What cancer stocks are investors taking seriously?: Allos Therapeutics... China Medical Technologies... Delcath Systems... Myriad Genetics... ZIOPHARM... |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Battle of the Bulge: Biotech Takes on Obesity and Diabetes Will recent advances in pharmaceutical research revolutionize the weight loss industry? It's still early days, but here are some of the stocks to watch. |
| <Older 7161-7170 Newer> Return to current articles. |
